Efficacy, safety, and dose comparison of degarelix for the treatment of prostate cancer: A systematic review and meta-analysis

doi:10.13105/wjma.v4.i3.69

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8763)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

424

WORD

350

HTML

3892

Figures (1-4)

140

Tables (1-3)

131

Sum=4937

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

457

Download

795

Sum=1252

Publishing Process of This Article

Item

Count

Browse

1012

Download

1562

Sum=2574

Jun 26, 2016 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Meta-Anal. Jun 26, 2016; 4(3): 69-76
Published online Jun 26, 2016. doi: 10.13105/wjma.v4.i3.69

Full Size Figure Download Figure

Figure 3 The effects of degarelix (240/80 mg) and goserelin (3. 6 mg) on mean International Prostate Symptom Score and International Prostate Symptom Score ≥ 13 within included studies. IPSS: International Prostate Symptom Score.

Citation: Fang C, Wu CL, Liu SS, Ge L, Bai JL. Efficacy, safety, and dose comparison of degarelix for the treatment of prostate cancer: A systematic review and meta-analysis. World J Meta-Anal 2016; 4(3): 69-76
URL: https://www.wjgnet.com/2308-3840/full/v4/i3/69.htm
DOI: https://dx.doi.org/10.13105/wjma.v4.i3.69